| scholarly article | Q13442814 |
| retracted paper | Q45182324 |
| P356 | DOI | 10.1002/JCB.26633 |
| P698 | PubMed publication ID | 29266445 |
| P50 | author | La-Mei Yu | Q89706651 |
| P2093 | author name string | Nai-Xuan Li | |
| Jing-Wu Sun | |||
| P2860 | cites work | Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor | Q24629279 |
| Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model | Q33780722 | ||
| Regulation of the protein C anticoagulant and antiinflammatory pathways | Q33996371 | ||
| Transgenic mice over-expressing ET-1 in the endothelial cells develop systemic hypertension with altered vascular reactivity | Q34077735 | ||
| Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes | Q34173401 | ||
| MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3. | Q34389043 | ||
| von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models | Q34666946 | ||
| TGF-beta regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. | Q34799828 | ||
| Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. | Q35141261 | ||
| Incidence of Deep Vein Thrombosis in Hospitalized Chinese Medical Patients and the Impact of DVT Prophylaxis | Q35536255 | ||
| A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time | Q35559573 | ||
| Prevalence and risk factors of deep vein thrombosis in patients after spine surgery: a retrospective case-cohort study | Q35808713 | ||
| Genetic associations for activated partial thromboplastin time and prothrombin time, their gene expression profiles, and risk of coronary artery disease | Q36096131 | ||
| Upregulation of miR-483-3p contributes to endothelial progenitor cells dysfunction in deep vein thrombosis patients via SRF. | Q36493764 | ||
| Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells | Q36545132 | ||
| STAT3: a critical transcription activator in angiogenesis. | Q36801186 | ||
| miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma | Q37191655 | ||
| Air pollution and venous thrombosis: a meta-analysis | Q37237418 | ||
| Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease | Q37818446 | ||
| STAT3, a key regulator of cell-to-cell communication in the heart | Q38187227 | ||
| Glycoproteomic analysis of human fibrinogen reveals novel regions of O-glycosylation | Q38320923 | ||
| miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression | Q38846721 | ||
| Evaluation of molecular genetic variation associated with deep venous thrombosis in lower limb fractures in traumatic patients | Q39375892 | ||
| MiR-495 and miR-218 regulate the expression of the Onecut transcription factors HNF-6 and OC-2. | Q39774767 | ||
| Investigation of prothrombin time in human whole-blood samples with a quartz crystal biosensor | Q39911448 | ||
| Role of blood transfusion product type and amount in deep vein thrombosis after cardiac surgery | Q40339594 | ||
| Independent Predictors of 30-Day Perioperative Deep Vein Thrombosis in 1346 Consecutive Patients After Spine Surgery. | Q40740376 | ||
| Epigenetic control of tissue-type plasminogen activator synthesis in human endothelial cells | Q42483304 | ||
| Functional assessment of a surgical robot for reduction of lower limb fractures | Q42674167 | ||
| Topographic organization of the ganglion cell layer and intraocular vascularization in the retinae of two reef teleosts | Q44212503 | ||
| Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis | Q46341327 | ||
| Diagnosis of acute aortic dissection by D-dimer: the International Registry of Acute Aortic Dissection Substudy on Biomarkers (IRAD-Bio) experience. | Q47824695 | ||
| MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway | Q48837549 | ||
| Upregulation of MicroRNA-126 Contributes to Endothelial Progenitor Cell Function in Deep Vein Thrombosis via Its Target PIK3R2 | Q51059554 | ||
| A new ultrasonographic technique for diagnosing deep venous insufficiency--imaging and functional evaluation of venous valves by ultrasonography with improved resolution. | Q51108613 | ||
| MicroRNA-495 regulates the proliferation and apoptosis of human umbilical vein endothelial cells by targeting chemokine CCL2 | Q51118725 | ||
| A panel of microRNAs as a new biomarkers for the detection of deep vein thrombosis | Q85356545 | ||
| P433 | issue | 7 | |
| P921 | main subject | thrombosis | Q261327 |
| microRNA | Q310899 | ||
| biomarker | Q864574 | ||
| P304 | page(s) | 5262-5273 | |
| P577 | publication date | 2018-03-12 | |
| P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
| P1476 | title | Evaluation of the circulating MicroRNA-495 and Stat3 as prognostic and predictive biomarkers for lower extremity deep venous thrombosis | |
| P478 | volume | 119 |
| Q90551041 | Circulating and tissue microRNAs as a potential diagnostic biomarker in patients with thrombotic events |
| Q102059545 | Downregulation of interleukin-6 and C-reactive protein underlies a novel inhibitory role of microRNA-136-5p in acute lower extremity deep vein thrombosis |
| Q57024561 | Effect of microRNA-495 on lower extremity deep vein thrombosis through the TLR4 signaling pathway by regulation of IL1R1 |
| Q94951502 | How microRNAs affect the PD-L1 and its synthetic pathway in cancer |
| Q92569972 | Interplay between genetics and epigenetics in modulating the risk of venous thromboembolism: A new challenge for personalized therapy |
| Q90521167 | MicroRNA (miRNA): A New Dimension in the Pathogenesis of Antiphospholipid Syndrome (APS) |
| Q91471151 | MicroRNA-495 serves as a diagnostic biomarker in patients with sepsis and regulates sepsis-induced inflammation and cardiac dysfunction |
| Q89527587 | MicroRNAs in venous thrombo-embolism |
| Q112582332 | Nomogram for Predicting Deep Venous Thrombosis in Lower Extremity Fractures |
| Q64056595 | Silica nanoparticles trigger the vascular endothelial dysfunction and prethrombotic state via miR-451 directly regulating the IL6R signaling pathway |
Search more.